Stallion starts Bhilwara R-32 project, targets FY27-28 topline
Key highlights
- Stallion received 10-year environmental clearance for the Bhilwara project on 28 December 2025.
- The Bhilwara site is planned for 10,000 MT per annum of R-32 and 7,500 MT per annum of blended refrigerants.
- Stallion expects Bhilwara commissioning in March 2027 and Rs 500-600 crore of FY27-28 topline potential.
- Management expects a 22% PAT margin from Bhilwara, versus Stallion's reported 10.10% PAT margin in FY25-26.
powered by IRIS

Stallion has begun construction of a 10,000 MT annual R-32 plant in Bhilwara following 28 December 2025 environmental clearance, and management targets March 2027 commissioning, with estimated FY27-28 topline potential of Rs 500-600 crore and an expected 22% PAT margin.
Know Stallion India Fluorochemicals inside out
Results, valuation, peers and who's buying, in one view.
What has Stallion started at Bhilwara?
Stallion has commenced work on a greenfield R-32 manufacturing facility at RIICO Industrial Area, Ukhaliya, in Rajasthan's Bhilwara district. The plant is designed for 10,000 metric tonnes (MT) of annual R-32 capacity, marking a move into manufacturing of a refrigerant molecule that Stallion identifies as part of its backward-integration strategy.
The project also includes 7,500 MT per annum of aggregate blended-refrigerant capacity and hydrochloric acid, or HCl, at 30% concentration as a by-product. The 10,000 MT capacity applies specifically to R-32 manufacturing, while the 7,500 MT figure applies to blended refrigerants, giving the Bhilwara site two disclosed refrigerant-capacity streams.
What approval and timetable does Stallion have for Bhilwara?
Stallion received environmental clearance from SEIAA, Rajasthan on 28 December 2025 for the proposed 10,000 MT R-32 facility. The clearance is valid for 10 years and categorises the project as Category B1 under the Synthetic Organic Chemicals Industry, supplying the regulatory milestone disclosed before construction began.
Construction has started in what Stallion describes as an accelerated mode, while commissioning is expected in March 2027. The disclosed timeline therefore spans about 15 months from the environmental-clearance date to the planned commissioning month, although the presentation gives no project-cost figure, funding plan or construction-stage milestones.
What revenue and margin does Stallion expect from Bhilwara?
Stallion estimates FY27-28 topline potential of Rs 500-600 crore from the Bhilwara project and expects a profit after tax, or PAT, margin of 22%. These are management expectations for a plant yet to be commissioned rather than reported revenue or profit, and the presentation labels the projected revenue period as FY27-28.
The 22% expected PAT margin is 11.90 percentage points above Stallion's reported 10.10% PAT margin in FY25-26. That comparison shows the margin improvement management associates with the manufacturing project, but the figures have different status: the FY25-26 margin is reported historical performance, while the 22% margin is a forward-looking project expectation.
Stallion's total income rose 14.40% to Rs 434.1230 crore in FY25-26 after increasing 60.64% in FY24-25. PAT grew 35.61% to Rs 43.8411 crore in FY25-26 and PAT margin increased from 8.52% in FY24-25 to 10.10%, whereas the proposed plant's Rs 500-600 crore topline range would exceed the company's FY25-26 total income if management achieves that estimate.
Got a follow-up? Ask IRIS
Why is Stallion adding R-32 manufacturing capacity?
Stallion says the 10,000 MT Bhilwara project will strengthen backward integration by giving it greater control over critical refrigerant molecules. Its stated rationale includes supply-chain resilience, manufacturing self-reliance and alignment with the transition to environmentally efficient refrigerants, alongside Make in India and Viksit Bharat manufacturing objectives.
The Bhilwara project sits alongside other disclosed initiatives, including an HFO and HFC blending and HFO debulking facility at Mambattu in Andhra Pradesh. Stallion also says its Khalapur facility has commenced operations in high-purity helium, while its wider strategy includes specialty and semiconductor gases for electronics and advanced-technology industries.
Management expects Stallion to grow at a 30-35% compound annual growth rate over the next three years while maintaining sustainable margins. It further says backward integration and higher-value products, including semiconductor gases, are intended to enhance profitability by 3-4%, though the presentation does not allocate that potential improvement between Bhilwara, semiconductor gases or other initiatives.
How does current performance compare with the Bhilwara plan?
Stallion reported total income of Rs 264.0490 crore in H1 FY27, up 22.07% from Rs 216.3031 crore in H1 FY26. Revenue from operations increased 19.18% to Rs 257.4775 crore, representing reported growth before the planned March 2027 commissioning of the Bhilwara facility.
Reported PAT fell 3.50% to Rs 21.0186 crore in H1 FY27 from Rs 21.7800 crore in H1 FY26, while employee benefits expense included Rs 9.5092 crore of employee stock option plan, or ESOP, charges. On Stallion's operating basis before the non-cash, equity-settled ESOP charge, operating PAT rose 40.16% to Rs 30.5278 crore, a separate measure from the project's expected 22% PAT margin.
Conclusion
Stallion has moved its Bhilwara R-32 proposal into construction after obtaining 10-year environmental clearance, with 10,000 MT of annual R-32 capacity and 7,500 MT of aggregate blended-refrigerant capacity planned for the site. Management's Rs 500-600 crore FY27-28 topline estimate and 22% expected PAT margin position the project as a significant part of its stated manufacturing and backward-integration strategy.
The next disclosed milestone is commissioning in March 2027. Progress against that timetable, and any future disclosure on project spending, funding, utilisation or the basis for the Rs 500-600 crore revenue range, will determine how the construction plan translates into reported financial results.


